GLP-1/GIP Oral Drops are a compounded, once-weekly, needle-free formulation designed to support weight management, appetite control, and metabolic health. This product uses a proprietary absorption system called EllievaTec™, which is designed to enhance delivery through the mouth. The drops contain a GLP-1/GIP receptor agonist and are formulated for sublingual use under the supervision of a licensed healthcare provider. While GLP-1/GIP therapies have been studied extensively in injectable form, this compounded oral version offers a convenient, non-injectable alternative. 

Important Disclaimer: GLP-1/GIP Oral Drops are compounded medications and have not been evaluated or approved by the Food and Drug Administration (FDA). They are intended for use only under the guidance of a licensed healthcare provider and must be dispensed by a 503A compounding pharmacy in accordance with applicable regulations. This product is not intended to diagnose, treat, cure, or prevent any disease. Individual results may vary. Always consult your primary care physician before starting any new treatment, as they have the most comprehensive understanding of your health history and can help ensure safe, coordinated care.

GLP-1/GIP Oral Drops may be beneficial for individuals looking to support healthy weight loss, manage appetite, or improve metabolic markers under the guidance of a licensed provider. They may also be used in cases of insulin resistance, prediabetes, or to support weight-related health goals. This product is especially suitable for those who prefer to avoid injections or want the convenience of a needle-free, oral alternative. Use should always be medically supervised, especially for individuals with pre-existing conditions or those taking other medications. This product is not FDA-approved and should only be used as prescribed through a 503A compounding pharmacy.

• Tier 1: Includes 1 bottle (5mL) at a 20mg/mL concentration
• Tier 2: Includes 2 bottles (5mL each) at a 20mg/mL concentration
• Tier 3: Includes 3 bottles (5mL each) at a 20mg/mL concentration

Duration will vary based on your prescribed dose and tier. Your provider will determine the appropriate amount based on your health history and progress.

Below is a common protocol, though dosing may be personalized at your provider's discretion. Always follow your prescription label:

• Tier 1:
  • Weeks 1-4: Take 0.25 mL by mouth once weekly
  • Weeks 5-8: Increase to 0.4 mL once weekly
  • Weeks 9-12: Increase to 0.55 mL once weekly
• Tier 2:
  • Weeks 1-4: Take 0.6 mL once weekly
  • Weeks 5-8: Increase to 0.75 mL once weekly
  • Weeks 9-12: Increase to 0.85 mL once weekly
• Tier 3:
  • Weeks 1-4: Take 0.9 mL once weekly
  • Weeks 5-8: Increase to 0.95 mL once weekly
  • Weeks 9-12: Increase to 1.0 mL once weekly

For all tiers: Place dose under the tongue, swish for 45 seconds, then swallow. Do not eat or drink for 30 minutes after dosing.

GLP-1/GIP therapy may not be appropriate for everyone. Do not use this product without medical supervision. It may not be suitable for individuals who:

• Have a personal or family history of medullary thyroid carcinoma (MTC) or MEN-2 syndrome
• Are pregnant, breastfeeding, or planning pregnancy
• Have a history of pancreatitis
• Have severe gastrointestinal conditions (e.g., gastroparesis)
• Are under 18 years of age
• Are allergic to GLP-1/GIP receptor agonists or any ingredients in the formulation

The most commonly reported side effects include:

• Nausea
• Vomiting
• Diarrhea
• Constipation
• Headache
• Fatigue

These are typically mild and may lessen as your body adjusts. Always report any side effects to your healthcare provider. In rare cases, more serious side effects may occur. Seek immediate care if you experience signs of an allergic reaction or persistent abdominal pain.

Yes, but only under medical supervision. GLP-1/GIP therapy may be used alongside other medications or peptide treatments like NAD+ or BPC-157/TB500. Your provider will determine if this combination is appropriate for your specific goals and medical profile.

Yes. Although a licensed provider will review your medical history before prescribing, we strongly encourage you to inform your primary care physician of any new treatments, including compounded peptides, to ensure coordinated and safe care.

GLP-1/GIP Oral Drops are compounded medications and have not been evaluated or approved by the Food and Drug Administration (FDA). They are intended for use only under the guidance of a licensed healthcare provider and must be dispensed by a 503A compounding pharmacy in accordance with applicable regulations. This product is not intended to diagnose, treat, cure, or prevent any disease. Individual results may vary. Always consult your primary care physician before starting any new treatment, as they have the most comprehensive understanding of your health history and can help ensure safe, coordinated care.